X Prize Foundation nixes genetics- oriented prize

Rapidly falling sequencing costs make prize a relatively moot point and result in first-ever X Prize cancellation
| 2 min read
Register for free to listen to this article
Listen with Speechify
0:00
2:00
First announced in 2006 and originally for the goal of sequencing 100 human genomes in 10 days for $1 million—a feat for which the winner would get $10 million—the Archon Genomics X Prize has been cancelled in 2013, marking the first prize program from the X Prize Foundation to ever be cancelled.
The genomics prize was a victim of rapid advances in sequencing. As the price of sequencing has plummeted, a prize to try to promote less expensive and faster sequencing efforts became a moot point.
Already, the Archon Genomics X Prize had been changed to a goal of sequencing 100 people of 100 years or older within 30 days at a cost of $1,000 or less each. But even that goal drew only two participants after recruitment began in 2011.
Announcing the cancellation of the prize by way of an article at the Huffington Post, X Prize Foundation Chairman and CEO Peter Diamandis wrote that "failure is not a bad thing; it is part of the process. We expect most ofour competing teams to fail as they attempt to achieve audacious goals.And sometimes, if we are doing our job right, an X Prize will fail aswell."
Continue reading below...
A black mosquito is shown on pink human skin against a blurred green backdrop.
InfographicsDiscovering deeper insights into malaria research
Malaria continues to drive urgent research worldwide, with new therapies and tools emerging to combat the parasite’s complex lifecycle and global burden.
Read More
The prizes, he noted, are meant to address industry failtures or voids and to encourage breakthroughs once thought impossible.
In this case, what was thought to be ambitious goals for which to shoot turned out to become unexpected breakthroughs earlier than anticipated.

While the prize will not be awarded and the fate of any future genomics X Prize efforts is uncertain, one thing did come of the effort. The 100 people aged 100 or older who donated their DNA to thecompetition still represent "a very exclusive groupwhose 'rare genes' may protect them from age-related diseases and helpthem continue to enjoy long and healthy lives," as the X Prize organizers put it, and their genomes are set to be sequenced and then stored in an open forum.

About the Author

Related Topics

Loading Next Article...
Loading Next Article...
Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

Fluorescent-style illustration of spherical embryonic stem cells clustered together against a dark background.
Explore how emerging in vitro systems — built from primary cells, cocultures, and vascularized tissues — are improving translational research outcomes. 
3D illustration of ciliated cells, with cilia shown in blue.
Ultraprecise proteomic analysis reveals new insights into the molecular machinery of cilia.
3D illustration showing a DNA double helix encapsulated in a transparent capsule, surrounded by abstract white and orange protein-like molecular structures against a blue background.
Discover an integrated analytical approach that unites identification, purification, and stability assessment for therapeutic molecules.
Drug Discovery News December 2025 Issue
Latest IssueVolume 21 • Issue 4 • December 2025

December 2025

December 2025 Issue

Explore this issue